Enliven Therapeutics Inc (ELVN)
R&D Expenses
$89.15M
TTM · Period ending: · USD
ELVN R&D Expenses
Latest reported$89.15Mperiod ending
Latest reported$89.15Mperiod ending
ELVN R&D Expenses ($7.92M → $89.15M)
Annual R&D Expenses
High-resolution chart · PNG
ELVN r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 85,856,000 | |
| 80,778,000 | |
| 64,574,000 | |
| 31,022,000 | |
| 20,474,000 | |
| 8,240,000 | |
| 19,009,000 | |
| 8,239,000 | |
| 7,918,000 |